Brind.
  1. Pfizer partnered with BioNTech to develop the Comirnaty vaccine, with Duality aiming to submit applications for US market entry.

BioNTech is facing performance issues leading to co-founders planning to leave the company by the end of 2026, with revenue dependent on the partnership with Pfizer.

1 report, 1 independent Updated Jul 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

BioNTech is facing performance issues leading to co-founders planning to leave the company by the end of 2026, with revenue dependent on the partnership with Pfizer.

Who's involved

What this event is mainly about
Uğur ŞahinÖzlem Türeci

Keep exploring

Part of

Pfizer partnered with BioNTech to develop the Comirnaty vaccine, with Duality aiming to submit applications for US market entry. All 2 developments

The entities involved

  • Uğur Şahin

    German oncologist, developer of COVID-19 vaccine

    Nothing else this week.

  • Özlem Türeci

    Turkish-German physician (born 1967)

    Nothing else this week.

Coverage

Newest first; wire copies grouped